Target intelligence / Profile preview

Tissue dissolution

Molecular classification
Other
01

Overview

Tissue dissolution is not a discrete molecular target such as a receptor or enzyme, but rather a therapeutic process or desired clinical outcome involving the breakdown and removal of biological tissues. It is a cornerstone of endodontic therapy, where chemical irrigants like sodium hypochlorite are used to dissolve organic pulp remnants and necrotic debris to ensure thorough disinfection of the root canal system [1][3]. Beyond dentistry, enzymatic tissue dissolution is utilized in treating fibrotic disorders such as Dupuytren's contracture and Peyronie's disease, where collagenases are injected to selectively degrade pathological collagen deposits [12][14]. The mechanism of action varies by agent, involving nonspecific chemical processes like saponification and chloramination for bleach-based irrigants, or site-specific proteolytic cleavage for enzymatic debriding agents [8][12]. While highly effective for clearing infection sites or reducing fibrotic tissue, the lack of inherent specificity in many dissolving agents poses significant safety risks, including chemical burns or damage to surrounding healthy tissue if not carefully controlled [10][13].

Other names
Tissue-dissolving activityPulp dissolutionNecrotic tissue dissolutionEnzymatic debridementOrganic tissue degradation
02

Mechanism of action

Nonspecific chemical degradation via oxidation, saponification, and chloramination; targeted enzymatic proteolysis of structural proteins like collagen and hyaluronic acid; fibrinolysis.

03

Biological functions

Extracellular matrix degradationProteolysisSaponificationTissue remodelingCell death
04

Disease associations

Endodontic infectionDupuytren's contracturePeyronie's diseaseChronic wound managementNecrosis
05

Safety considerations

Chemical burns to healthy tissueSystemic toxicity upon extrusionPeriapical irritationTissue necrosis of non-target areasHypersensitivity reactions to foreign enzymes
06

Interacting drugs

Sodium hypochlorite

6 more in the full profile.

07

Biomarkers

Residual tissue massHydroxyproline concentrationC-terminal telopeptide of type I collagen (CTX)D-dimer

Beyond the preview

Go deeper on Tissue dissolution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue dissolution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call